Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

TET2 overexpression in chronic lymphocytic leukemia is unrelated to the presence of TET2 variations.

BioMed research international - 1 Jan 2014

Hernández-Sánchez María, Rodríguez Ana Eugenia, Kohlmann Alexander, Benito Rocío, García Juan Luis, Risueño Alberto, Fermiñán Encarna, De Las Rivas Javier, González Marcos, Hernández-Rivas Jesús-María

Abstract excerpt

TET2 is involved in a variety of hematopoietic malignancies, mainly in myeloid malignancies. Most mutations of TET2 have been identified in myeloid disorders, but some have also recently been described in mature lymphoid neoplasms. In contrast to the large amount of data about mutations of TET2, some data are available for gene expression. Moreover, the role of TET2 in chronic lymphocytic leukemia (CLL) is...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to B-Lymphocytes
Share to Clone Cells

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Dioxygenases

Share to DNA-Binding Proteins

Share to Gene Expression Regulation, Leukemic

Share to High-Throughput Nucleotide Sequencing

Share to Leukemia, Lymphocytic, Chronic, B-Cell

Share to Proto-Oncogene Proteins

Source

Open in PubMed Open full text

Identifiers

PMID: 24693539
DOI: 10.1155/2014/814294
PMCID: PMC3947698

Genes

TET2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

TET2 overexpression in chronic lymphocytic leukemia is unrelated to the presence of TET2 variations.PMID 24693539Read ↗

Characterization of TET and IDH gene expression in chronic lymphocytic leukemia: comparison with normal B cells and prognostic significanceSemantic proximity Read ↗

TET2 gene mutation is a frequent and adverse event in chronic myelomonocytic leukemia.Semantic proximity Read ↗

Molecular profiling of chronic myelomonocytic leukemia reveals diverse mutations in >80% of patients with TET2 and EZH2 being of high prognostic relevanceSemantic proximity Read ↗

TET2 deletions are a recurrent but rare phenomenon in myeloid malignancies and are frequently accompanied by TET2 mutations on the remaining allele.Semantic proximity Read ↗

[TET2 dysregulation in hematologic malignancies].Semantic proximity Read ↗

Significance of TET2 mutations in myeloid and lymphoid neoplasms.Semantic proximity Read ↗

A meta-analysis of TET2 mutations shows a distinct distribution pattern in de novo acute myeloid leukemia and chronic myelomonocytic leukemia.Semantic proximity Read ↗

Number and type of TET2 mutations in chronic myelomonocytic leukemia and their clinical relevanceSemantic proximity Read ↗

TET2 Mutation in Adult T-Cell Leukemia/Lymphoma.Semantic proximity Read ↗

Research Advances in the Mutation of TET2 Gene in Myeloid Maligancies.Semantic proximity Read ↗

[Mutations in TET2 in myeloid cancers].Semantic proximity Read ↗

TET2 inactivation results in pleiotropic hematopoietic abnormalities in mouse and is a recurrent event during human lymphomagenesis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.